Vimarsana
Biggest News Aggregation in the World

Intelligent Systems Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Intelligent Systems Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Intelligent Systems Program Today - Breaking & Trending Today

Electrical and Behavioral Signals in OCD Could Guide Adaptive Therapy - Vimarsana News

Electrical and Behavioral Signals in OCD Could Guide Adaptive Therapy

Researchers hope that an adaptive DBS that can adjust stimulation intensity in response to symptoms may provide more relief and fewer side effects for patients.

SCI dean search committee hears community wish lists - Vimarsana News

SCI dean search committee hears community wish lists

By SUSAN JONES The search committee for the new dean of the School of Computing and Information is wrapping up the first phase of its process after holding four forums last week to get input from faculty, staff, students and the University community. Paul Cohen, SCI founding dean, stepped down from that role and returned to the faculty in July 2020. Bruce Childers, senior

Source: pitt.edu
Ocugen Establishes Vaccine Scientific Advisory BoardLeading experts to evaluate the clinical and regulatory path to approval in the US market of COVAXIN™, a whole-virion inactivated COVID-19 vaccine - Vimarsana News

Ocugen Establishes Vaccine Scientific Advisory BoardLeading experts to evaluate the clinical and regulatory path to approval in the US market of COVAXIN™, a whole-virion inactivated COVID-19 vaccine

Published: Dec 23, 2020 MALVERN, Pa., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Ocugen, Inc., (NASDAQ: OCGN), a leading biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies, today announced the appointment of a vaccine scientific advisory board comprised of leading academic and industry experts in the vaccine field to evaluate the clinical and regulatory path to approval in the US market of Bharat Biotech’s COVAXIN™, a whole-virion inactivated COVID-19 vaccine candidate to be co-developed by Ocugen and Bharat Biotech for the US m...